[Parkinsonism and use of selective serotonin uptake inhibitors]

Tidsskr Nor Laegeforen. 2003 Apr 3;123(7):947-8.
[Article in Norwegian]
No abstract available

MeSH terms

  • Antidepressive Agents, Second-Generation / adverse effects
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use
  • Depression / drug therapy*
  • Depression / etiology
  • Depression / prevention & control
  • Drug Interactions
  • Humans
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy
  • Parkinson Disease / psychology
  • Parkinsonian Disorders / complications
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / psychology
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

  • Antidepressive Agents, Second-Generation
  • Antiparkinson Agents
  • Monoamine Oxidase Inhibitors
  • Serotonin Uptake Inhibitors